ABIVAX Competitors

AAVXF Stock

USD 12.36 0.00 0.00%

ABIVAX Socit Anonyme competes with Novo Nordisk, Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Seagen, and JAKKS Pacific; as well as few others. The company classifies itself under Healthcare sector and is part of Biotechnology industry. Analyzing ABIVAX Socit competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of ABIVAX Socit to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out ABIVAX Socit Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of ABIVAX Socit competition on your existing holdings.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of ABIVAX Socit's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of ABIVAX Socit in the context of predictive analytics.

Hype

Prediction

Low	Estimated	High
8.13	12.36	16.59

Details

Intrinsic

Valuation

Low	Real	High
9.58	13.81	18.04

Details

Naive

Forecast

Low	Next	High
6.43	10.66	14.89

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
12.36	12.36	12.36

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as ABIVAX Socit. Your research has to be compared to or analyzed against ABIVAX Socit's peers to derive any actionable benefits. When done correctly, ABIVAX Socit's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ABIVAX Socit Anonyme.

ABIVAX Socit Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between ABIVAX Socit and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of ABIVAX and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of ABIVAX Socit Anonyme does not affect the price movement of the other competitor.

	NVO	VRTX	REGN	SGEN	JAKK
NVO		0.37	-0.22	0.19	0.67	NVO
VRTX	0.37		-0.03	0.54	0.03	VRTX
REGN	-0.22	-0.03		-0.3	-0.3	REGN
SGEN	0.19	0.54	-0.3		0.15	SGEN
JAKK	0.67	0.03	-0.3	0.15		JAKK
	NVO	VRTX	REGN	SGEN	JAKK

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

JAKK	+ 0.67	NVO
SGEN	+ 0.54	VRTX
VRTX	+ 0.37	NVO
SGEN	+ 0.19	NVO
JAKK	+ 0.15	SGEN
JAKK	+ 0.03	VRTX

High negative correlations

JAKK	- 0.3	REGN
SGEN	- 0.3	REGN
REGN	- 0.22	NVO
REGN	- 0.03	VRTX

Risk-Adjusted Indicators

There is a big difference between ABIVAX Pink Sheet performing well and ABIVAX Socit company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ABIVAX Socit's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Information Ratio	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NVO	1.39	0.09	0.05	0.12	1.69	0.0479	(1.36)	3.10	(2.79)	9.16
VRTX	1.09	0.02	0.01	0.03	1.48	0.0123	(1.15)	1.99	(1.95)	8.11
REGN	0.77	(0.02)	0.00	(0.03)	0.00	(0.0186)	0.00	1.88	(1.60)	6.22
SGEN	0.46	0.05	0.11	0.98	0.37	0.08	(0.60)	1.10	(0.63)	5.21
JAKK	2.62	0.72	0.33	0.21	1.78	0.14	(3.44)	6.81	(3.74)	38.95

ABIVAX Socit Competitive Analysis

The better you understand ABIVAX Socit competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, ABIVAX Socit's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across ABIVAX Socit's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	AAVXF	NVO	VRTX	REGN	SGEN	JAKK
	0.00 12.36 ABIVAX	2.02 97.62 Novo	0.19 353.48 Vertex	1.84 835.98 Regeneron	0.009267 215.81 Seagen	0.94 29.94 JAKKS
Market Volatility (90 Days Market Risk)	Somewhat reliable	Very steady	Very steady	Very steady	Very steady	Not too volatile
Market Performance (90 Days Performance)	Very Weak	Weak	Insignificant	Very Weak	OK	Good
Odds of Financial Distress (Probability Of Bankruptcy)	Above Average	Very Small	Very Small	Very Small	Below Average	Very Low
Current Valuation (Equity Enterprise Value)	Under Valued	Under Valued	Under Valued	Fairly Valued	Over Valued	Fairly Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Buy	Buy	Buy	Hold	Strong Buy
Trade Advice (90 Days Macroaxis Advice)	Hold	Strong Buy	Strong Hold	Strong Buy	Buy	Strong Buy
Current Ratio	2.03 X	0.92 X	4.70 X	5.36 X	4.57 X	1.47 X
Net Asset	110.36 M	241.26 B	18.15 B	29.21 B	3.67 B	399.3 M
Profit Margin	N/A	0.35 %	0.36 %	0.30 %	(0.33) %	0.12 %
EBITDA	(42.25 M)	82.04 B	4.35 B	5.17 B	(623.62 M)	64.1 M
Operating Margin	4.66 %	0.46 %	0.44 %	0.36 %	(0.35) %	0.20 %
Current Valuation	165.28 M	430.75 B	79.17 B	80.35 B	39.09 B	244.41 M
Price To Book	27.57 X	32.72 X	5.48 X	3.56 X	15.77 X	1.52 X
Retained Earnings	N/A	80.59 B	6.52 B	23.31 B	(2.15 B)	(112.02 M)
Current Asset	N/A	8.03 B	1.41 B	2.92 B	771.06 M	382.37 M
Five Year Return	N/A	2.05 %	N/A	N/A	N/A	N/A
Beta	1.26	0.19	0.42	0.14	0.32	2.46
Number Of Employees	24	61.41 K	4.8 K	12.46 K	3.26 K	622
Shares Outstanding	22.3 M	4.46 B	257.68 M	107.13 M	188.66 M	10.07 M
Cash Flow From Operations	(45.66 M)	78.89 B	4.13 B	5.01 B	(453.75 M)	86.1 M
Annual Yield	N/A	0.0102 %	N/A	0.0078 %	0.0319 %	0.06 %
Total Debt	53.45 M	25.78 B	561 M	2.7 B	43.47 M	87.76 M
Return On Equity	-12.86	0.89	0.23	0.17	-0.28	0.55
Z Score	1.8	12.8	99.09	22.57	N/A	4.55
Return On Asset	-0.44	0.22	0.14	0.0921	-0.13	0.0741
Book Value Per Share	0.36 X	20.77 X	64.05 X	234.47 X	13.52 X	19.66 X
Number Of Shares Shorted	N/A	4.43 M	2.51 M	1.4 M	10.2 M	273.49 K
Current Liabilities	N/A	5.95 B	506.35 M	811.16 M	134.27 M	127.4 M
Total Asset	110.36 M	241.26 B	18.15 B	29.21 B	3.67 B	399.3 M
Debt To Equity	8.03 %	0.34 %	0.06 %	0.13 %	0.021 %	1.35 %
Short Ratio	N/A	1.31 X	1.79 X	2.74 X	7.64 X	1.99 X
Target Price	N/A	84.37	400.0	920.09	228.91	28.0
Last Dividend Paid	N/A	7.08	N/A	N/A	N/A	N/A
Shares Owned By Institutions	57.27 %	8.22 %	96.54 %	89.44 %	85.40 %	47.67 %
Market Capitalization	165.36 M	452.96 B	90.35 B	88.85 B	40.72 B	308.65 M
Price To Earning	(7.88) X	37.42 X	24.57 X	15.51 X	32.75 X	4.08 X
Price To Earnings To Growth	N/A	4.02 X	0.50 X	1.75 X	18.53 X	2.37 X
Price To Sales	20.65 X	2.14 X	9.37 X	6.76 X	17.70 X	0.42 X
Net Income	(41.36 M)	55.52 B	3.32 B	4.34 B	(610.31 M)	91.08 M
Earnings Per Share	(2.59) X	2.44 X	13.32 X	35.08 X	(4.06) X	8.26 X
Shares Owned By Insiders	4.67 %	0.007 %	0.16 %	2.54 %	0.91 %	27.60 %
Revenue	37 K	176.95 B	8.93 B	12.17 B	1.96 B	796.19 M
Working Capital	N/A	(12.75 B)	10.25 B	17.5 B	1.98 B	101.91 M
Cash And Equivalents	26.57 M	37.47 B	9.77 B	7.02 B	1.85 B	62.28 M
Cash Per Share	1.58 X	16.57 X	38.06 X	65.75 X	10.03 X	6.41 X
Gross Profit	(45.52 M)	148.51 B	5.32 B	7.02 B	207.99 M	219.96 M
Day Typical Price	N/A	98.16	353.64	834.22	215.84	30.32
Accumulation Distribution	N/A	49968.77	13403.42	8660.07	3282.2	4461.5
Daily Balance Of Power	N/A	(1.20)	(0.13)	0.885	(0.017544)	0.2171
Rate Of Daily Change	N/A	0.98	1.0	1.02	1.0	1.01
Day Median Price	N/A	98.43	353.72	833.34	215.85	30.51
Price Action Indicator	N/A	(1.81)	(0.57)	10.18	(0.05)	(0.42)
Coefficient Of Variation	(666.05)	1956.48	6077.83	(7,760)	1169.83	700.62
Mean Deviation	1.22	1.39	1.09	0.7662	0.4634	2.62
Jensen Alpha	(0.63)	0.0875	0.0151	(0.020547)	0.0496	0.7221
Total Risk Alpha	(0.61)	0.0942	0.0206	(0.017946)	0.053	0.7345
Sortino Ratio	N/A	0.0474	0.0114	N/A	0.1136	0.3275
Downside Variance	N/A	3.49	2.29	N/A	0.2213	4.73
Standard Deviation	4.13	1.85	1.41	1.04	0.6945	5.03
Kurtosis	56.75	1.07	2.4	1.5	9.41	32.79
Potential Upside	N/A	3.1	1.99	1.88	1.1	6.81
Treynor Ratio	(1.08)	0.1152	0.0272	(0.03323)	0.9794	0.2061
Maximum Drawdown	32.45	9.16	8.11	6.22	5.21	38.95
Variance	17.05	3.42	1.98	1.09	0.4823	25.31
Market Risk Adjusted Performance	(1.07)	0.1252	0.0372	(0.02323)	0.9894	0.2161
Risk Adjusted Performance	(0.11)	0.0455	0.0173	(0.007473)	0.0652	0.1194
Skewness	(7.40)	0.299	(0.89)	0.3074	2.08	4.99
Semi Deviation	N/A	1.69	1.48	N/A	0.3721	1.78
Information Ratio	(0.15)	0.0479	0.0123	(0.018556)	0.077	0.1416
Value At Risk	N/A	(2.79)	(1.95)	(1.60)	(0.63)	(3.74)
Expected Short fall	N/A	(1.36)	(1.15)	N/A	(0.60)	(3.44)
Downside Deviation	N/A	1.87	1.51	N/A	0.4704	2.17
Semi Variance	N/A	2.86	2.19	N/A	0.1385	3.17

ABIVAX Socit Competition Performance Charts

Five steps to successful analysis of ABIVAX Socit Competition

ABIVAX Socit's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by ABIVAX Socit Anonyme in relation to its competition. ABIVAX Socit's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of ABIVAX Socit in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact ABIVAX Socit's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to ABIVAX Socit Anonyme, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your ABIVAX Socit position

In addition to having ABIVAX Socit in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Realty Funds Thematic Idea Now

Realty Funds

Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 39 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.

View All Next

Launch

Check out ABIVAX Socit Correlation with its peers.

You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for ABIVAX Pink Sheet analysis

When running ABIVAX Socit's price analysis, check to measure ABIVAX Socit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Socit is operating at the current time. Most of ABIVAX Socit's value examination focuses on studying past and present price action to predict the probability of ABIVAX Socit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Socit's price. Additionally, you may evaluate how the addition of ABIVAX Socit to your portfolios can decrease your overall portfolio volatility.

	Stocks Directory Find actively traded stocks across global markets
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume

Please note, there is a significant difference between ABIVAX Socit's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABIVAX Socit is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABIVAX Socit's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

ABIVAX Competitors

Specify up to 10 symbols:

ABIVAX Socit Competition Correlation Matrix

Risk-Adjusted Indicators

ABIVAX Socit Competitive Analysis

ABIVAX Socit Competition Performance Charts

Five steps to successful analysis of ABIVAX Socit Competition

Complement your ABIVAX Socit position

Did You Try This Idea?

Run Realty Funds Thematic Idea Now

Realty Funds

Complementary Tools for ABIVAX Pink Sheet analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY